Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Buerger-Allen Exercises and Peripheral Circulation in Sedentary Office Workers (BAE-CIRC)

9 de mayo de 2026 actualizado por: BUSENUR KARAGÖZ, Istanbul Gelisim University

Acute Effects of Buerger-Allen Exercises on Lower Extremity Circulatory Parameters in Sedentary Office Workers: A Single-Group Pretest-Posttest Clinical Trial

This study aims to evaluate the acute effects of Buerger-Allen exercises on lower extremity circulation in sedentary office workers. Prolonged sitting is associated with reduced venous return, impaired peripheral circulation, and endothelial dysfunction. Buerger-Allen exercises are simple position-based exercises designed to enhance arterial blood flow, venous return, and tissue perfusion. Thirty-five healthy sedentary adults aged 18 to 45 years will participate in this single-group pretest-posttest clinical trial. Skin surface temperature, capillary refill time, ankle-brachial index, peripheral oxygen saturation, and heart rate will be measured before and after a single 20-minute exercise session. The findings may support the use of Buerger-Allen exercises as a practical, low-cost physiotherapy strategy to improve peripheral circulation and reduce the adverse vascular effects of prolonged sitting.

Descripción general del estudio

Descripción detallada

Sedentary behavior and prolonged sitting are associated with impaired venous return, reduced peripheral blood flow, endothelial dysfunction, and increased cardiovascular risk. Office workers who remain seated for extended periods may experience lower extremity discomfort, edema, and early circulatory impairment.

Buerger-Allen exercises are position-based therapeutic exercises that involve sequential elevation, dependency, and horizontal rest of the lower limbs. These exercises are designed to promote arterial inflow, facilitate venous return, and enhance tissue perfusion without requiring specialized equipment. Previous studies have demonstrated beneficial effects in patients with peripheral vascular disease and diabetes, but evidence regarding their acute effects in healthy sedentary adults is limited.

This study will use a quasi-experimental single-group pretest-posttest design to investigate the immediate effects of Buerger-Allen exercises on lower extremity circulation in sedentary office workers. A total of 35 participants aged 18 to 45 years will be recruited from Istanbul Gelisim University. All participants will complete a standardized 20-minute Buerger-Allen exercise protocol.

Primary outcome measures will include skin surface temperature assessed with infrared thermometry, capillary refill time, ankle-brachial index, peripheral oxygen saturation, and heart rate. Measurements will be performed at baseline, immediately after the intervention, and 10 minutes after the intervention.

The study is expected to provide evidence regarding the effectiveness of a simple and low-cost physiotherapy intervention for improving peripheral circulation and preventing the adverse vascular effects associated with prolonged sedentary behavior.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

35

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Busenur KARAGÖZ, MSc
  • Número de teléfono: +90 534 062 71 24
  • Correo electrónico: buse.nur97e@gmail.com

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

      • Istanbul, Turquía (Türkiye)
        • Istanbul Gelisim University
        • Contacto:
          • Busenur KARAGÖZ, MSc
          • Número de teléfono: +90 534 062 71 24
          • Correo electrónico: buse.nur97e@gmail.com
        • Contacto:
          • Gökay ÇAKIROĞLU, PT

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Healthy sedentary office workers
  • Age between 18 and 45 years
  • Sitting for at least 6 hours per day for work-related activities
  • Not meeting regular physical activity recommendations
  • Willing to participate voluntarily and provide written informed consent

Exclusion Criteria:

  • History of peripheral arterial disease, deep vein thrombosis, or other vascular disorders
  • Cardiovascular, neurological, or musculoskeletal conditions that may affect lower extremity circulation or prevent exercise participation
  • Diabetes mellitus
  • Current smoking
  • Pregnancy
  • Use of medications that may significantly affect peripheral circulation
  • Lower extremity injury or surgery within the previous 6 months
  • Participation in regular structured exercise programs

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Buerger-Allen Exercise Group
Participants will perform a single standardized 20-minute Buerger-Allen exercise session. Lower extremity circulatory parameters will be assessed before the intervention, immediately after the intervention, and 10 minutes after the intervention.
The intervention consists of a standardized Buerger-Allen exercise protocol involving three sequential positions: (1) elevation of the lower limbs above heart level to facilitate venous return, (2) dependency of the lower limbs to promote arterial blood flow, and (3) horizontal supine rest to stabilize circulation. The complete exercise session lasts approximately 20 minutes and is performed once. Lower extremity circulatory parameters are assessed at baseline, immediately after the intervention, and 10 minutes after the intervention.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Skin Surface Temperature
Periodo de tiempo: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
Skin surface temperature measured with an infrared thermometer in degrees Celsius (°C). Higher values indicate increased peripheral blood flow and tissue perfusion.
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
Capillary Refill Time
Periodo de tiempo: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
Capillary refill time measured in seconds. Shorter times indicate improved peripheral microcirculation and tissue perfusion.
Baseline, Immediately After Intervention, and 10 Minutes After Intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Ankle-Brachial Index (ABI)
Periodo de tiempo: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
Ratio of ankle to brachial systolic blood pressure used to assess lower extremity arterial circulation. Higher values within the normal range indicate better arterial perfusion.
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
Peripheral Oxygen Saturation (SpO₂)
Periodo de tiempo: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
Oxygen saturation measured by pulse oximetry and expressed as a percentage (%). Higher values indicate improved peripheral oxygenation.
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
Heart Rate
Periodo de tiempo: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
Heart rate measured by pulse oximetry and expressed in beats per minute (bpm).
Baseline, Immediately After Intervention, and 10 Minutes After Intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Busenur KARAGÖZ, MSc, Istanbul Gelisim University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de junio de 2026

Finalización primaria (Estimado)

1 de septiembre de 2026

Finalización del estudio (Estimado)

1 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

9 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

9 de mayo de 2026

Publicado por primera vez (Actual)

15 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

15 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • IGU-FTR-BAE-2026-001
  • 2209A-2025Fall-Submitted (Otro identificador: The Scientific and Technological Research Council of Türkiye (TUBITAK))

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be made publicly available because no formal data-sharing plan has been established for this investigator-initiated academic study.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir